Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Primary Care

Management, Surveillance & Building Your Care Team

At a Glance

Care for distal 16p11.2 microdeletion is individualized and works best through a coordinated primary care team that monitors weight, blood sugar, organ health, development, and urgent symptoms while connecting families with specialists, therapies, and school supports.

Managing a diagnosis of Distal 16p11.2 (BP2-BP3) microdeletion requires a proactive and organized approach. Because this deletion affects multiple systems—especially metabolism and neurodevelopment—care is most effective when coordinated through a Medical Home [1]. This is typically your primary care doctor or pediatrician, who acts as the “quarterback” for your care team, ensuring all specialists are communicating and that no part of your health is overlooked [1][2].

Your Multidisciplinary Care Team

Because the symptoms of this deletion are so variable, your team will be tailored to your specific needs. Common specialists include:

  • Endocrinologist: Essential for monitoring growth, severe early-onset obesity, and the risk of early-onset type 2 diabetes [3][4].
  • Developmental Pediatrician: Focuses on milestones, learning, and behavior, including screening for Autism Spectrum Disorder (ASD) or ADHD [5][6].
  • Geneticist & Genetic Counselor: Provides guidance on the specific genes involved and helps with family testing and future planning [7][8].
  • Neurologist: Involved if there are concerns about seizures, significant low muscle tone (hypotonia), or structural brain differences [9][10].
  • Therapy Team: Includes Speech-Language Pathologists (SLP) for speech delays, Physical Therapists (PT) for motor coordination, and Occupational Therapists (OT) for sensory processing and daily living skills [11][12][13].

Recommended Monitoring and Surveillance

While there is no single “universal” schedule for this rare deletion, medical experts recommend individualized monitoring based on the known metabolic and developmental risks [3][4].

Area of Focus Clinician Discussion Points
Metabolic Health Weight/BMI trajectory, blood pressure, fasting glucose, and HbA1c [4][3]. Monitor regularly depending on age and weight changes [4].
Organ Function Lipid panel (cholesterol), liver enzymes (for NAFLD), and Cystatin C or creatinine (for kidney health) [3][4]. Should be symptom- and comorbidity-based.
Development Speech, motor skills, social communication, and behavior [6][14]. Formal re-evaluations at major school transitions.
Physical Health Spine screening for scoliosis (more commonly associated with broader 16p11.2) [15], vision, and hearing [16]. Referrals are symptom-based.

Educational and Day-to-Day Advocacy

For children, the neurodevelopmental challenges associated with the BP2-BP3 deletion often require specialized support [1][2].

  • IEPs and 504 Plans: You may need to advocate for an Individualized Education Program (IEP) or a 504 Plan. Eligibility depends on functional impact and formal school evaluation, not just the diagnosis itself [1].
  • Early Intervention: If your child is under age three, look for state-funded early intervention programs that can provide PT, OT, and speech therapy in your home [13].
  • Nutritional Environment: Because the deletion can cause a biological drive for food (hyperphagia), creating a low-stress, structured food environment at home and school is a key management strategy [4][17].

When to Seek Urgent Care

Be aware of signs that require immediate evaluation:

  • Seizures: Unexplained jerking movements or sudden loss of awareness [18].
  • Metabolic Signs: Excessive, unquenchable thirst, frequent urination, unexplained rapid weight loss.
  • Breathing Issues: Witnessed breathing pauses during sleep or extreme daytime sleepiness.

Common questions in this guide

Who should coordinate care for distal 16p11.2 microdeletion?
A primary care doctor or pediatrician can act as the medical home, coordinating records, referrals, and follow-up across specialists. Depending on individual needs, the team may include metabolism specialists, developmental clinicians, genetics professionals, neurology, and speech, physical, or occupational therapists.
What health checks are usually needed with distal 16p11.2 microdeletion?
Monitoring is individualized, but clinicians may follow growth and body mass index, blood pressure, fasting glucose, and HbA1c. Depending on symptoms and other health conditions, they may also check cholesterol, liver enzymes, and kidney function.
When might a child with this deletion need a pediatric endocrinologist?
Not every person needs the same endocrinology schedule. A primary care clinician may recommend referral when there is severe early-onset obesity, concerning weight changes, abnormal blood sugar, or other metabolic concerns; timing depends on age, symptoms, and test results.
What school and therapy supports may help a child with this deletion?
Children may benefit from speech, physical, or occupational therapy and, when under age three, state early-intervention services. An IEP or 504 Plan may provide school accommodations when a formal evaluation shows that developmental, learning, communication, or physical needs affect school activities.
Which symptoms need urgent medical attention?
Seek immediate medical evaluation for unexplained jerking movements or sudden loss of awareness, excessive thirst with frequent urination, unexplained rapid weight loss, or breathing pauses during sleep with marked daytime sleepiness. If symptoms are severe or rapidly worsening, follow local emergency-care guidance.
What records should I organize before seeing new specialists?
Keep the genetic report, growth measurements, laboratory results, specialist notes, therapy records, and school evaluations in one accessible file. A brief summary of current symptoms and priorities can help new clinicians understand the BP2-BP3 deletion and coordinate care.

Get notified when new evidence is published on Distal 16p11.2 microdeletion syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Health supervision for children and adolescents with 16p11.2 deletion syndrome.

    Chung WK, Herrera FF,

    Cold Spring Harbor molecular case studies 2023; (9(4)) doi:10.1101/mcs.a006316.

    PMID: 38050025
  2. 2

    Who ever heard of 16p11.2 deletion syndrome? Parents' perspectives on a susceptibility copy number variation syndrome.

    Kleinendorst L, van den Heuvel LM, Henneman L, van Haelst MM

    European journal of human genetics : EJHG 2020; (28(9)):1196-1204 doi:10.1038/s41431-020-0644-6.

    PMID: 32415274
  3. 3

    Chromosomal deletions on 16p11.2 encompassing SH2B1 are associated with accelerated metabolic disease.

    Hanssen R, Auwerx C, Jõeloo M, et al.

    Cell reports. Medicine 2023; (4(8)):101155 doi:10.1016/j.xcrm.2023.101155.

    PMID: 37586323
  4. 4

    Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion.

    Giannopoulou EZ, Zorn S, Schirmer M, et al.

    Hormone research in paediatrics 2022; (95(2)):137-148 doi:10.1159/000520402.

    PMID: 34689140
  5. 5

    The Phenotypic variability of 16p11.2 distal BP2-BP3 deletion in a transgenerational family and in neurodevelopmentally ascertained samples.

    Woodbury-Smith M, D'Abate L, Stavropoulos DJ, et al.

    Journal of medical genetics 2023; (60(12)):1153-1160 doi:10.1136/jmg-2022-108818.

    PMID: 37290907
  6. 6

    Developmental trajectories for young children with 16p11.2 copy number variation.

    Bernier R, Hudac CM, Chen Q, et al.

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2017; (174(4)):367-380 doi:10.1002/ajmg.b.32525.

    PMID: 28349640
  7. 7

    [Prenatal ultrasound and genetic characteristics of 60 fetuses with 16p11.2 microdeletion].

    Pan L, Wu J, Duan S, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2026; (51(4)):737-743 doi:10.11817/j.issn.1672-7347.2026.260007.

    PMID: 42394496
  8. 8

    Evaluation of 100 Dutch cases with 16p11.2 deletion and duplication syndromes; from clinical manifestations towards personalized treatment options.

    Vos N, Kleinendorst L, van der Laan L, et al.

    European journal of human genetics : EJHG 2024; (32(11)):1387-1401 doi:10.1038/s41431-024-01601-2.

    PMID: 38605127
  9. 9

    16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort.

    Steinman KJ, Spence SJ, Ramocki MB, et al.

    American journal of medical genetics. Part A 2016; (170(11)):2943-2955 doi:10.1002/ajmg.a.37820.

    PMID: 27410714
  10. 10

    [Clinical phenotype and genetic features of 16p11.2 microdeletion-related epilepsy in children].

    Lai CY, Chen RH, Zhong CL, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2022; (24(5)):585-590 doi:10.7499/j.issn.1008-8830.2111110.

    PMID: 35644201
  11. 11

    Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion.

    Mei C, Fedorenko E, Amor DJ, et al.

    European journal of human genetics : EJHG 2018; (26(5)):676-686 doi:10.1038/s41431-018-0102-x.

    PMID: 29445122
  12. 12

    Quantitative gait assessment in children with 16p11.2 syndrome.

    Goldman S, McCullough AK, Young SD, et al.

    Journal of neurodevelopmental disorders 2019; (11(1)):26 doi:10.1186/s11689-019-9286-9.

    PMID: 31656164
  13. 13

    Developmental presentation, medical complexities, and service delivery for a child with 16p11.2 deletion syndrome.

    Bamonte L

    Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association 2015; (27(1)):90-9 doi:10.1097/PEP.0000000000000105.

    PMID: 25521272
  14. 14

    Sensory processing in 16p11.2 deletion and 16p11.2 duplication.

    Smith H, Lane C, Al-Jawahiri R, Freeth M

    Autism research : official journal of the International Society for Autism Research 2022; (15(11)):2081-2098 doi:10.1002/aur.2802.

    PMID: 36053814
  15. 15

    TBX6 null variants and a common hypomorphic allele in congenital scoliosis.

    Wu N, Ming X, Xiao J, et al.

    The New England journal of medicine 2015; (372(4)):341-50 doi:10.1056/NEJMoa1406829.

    PMID: 25564734
  16. 16

    Ocular Findings in the 16p11.2 Microdeletion Syndrome: A Case Report and Literature Review.

    Stingl CS, Jackson-Cook C, Couser NL

    Case reports in pediatrics 2020; (2020()):2031701 doi:10.1155/2020/2031701.

    PMID: 32373379
  17. 17

    Measuring hyperphagia in patients with monogenic and syndromic obesity.

    Zorn S, von Schnurbein J, Schirmer M, et al.

    Appetite 2022; (178()):106161 doi:10.1016/j.appet.2022.106161.

    PMID: 35809703
  18. 18

    A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants.

    Chawner SJRA, Doherty JL, Anney RJL, et al.

    The American journal of psychiatry 2021; (178(1)):77-86 doi:10.1176/appi.ajp.2020.20010015.

    PMID: 33384013

This page is for informational purposes only and does not constitute medical advice. Your genetics, primary care, and specialty teams should tailor surveillance and urgent-care decisions to the individual.

Guide contents Distal 16p11.2 microdeletion syndrome
Research & Literature
05 Diagnostics & Pathology